已发表论文

T 辅助细胞中的 m6A 修饰调节自身免疫性疾病的发病机制

 

Authors Jiang Q, Wang X, Wu Y, Cui D 

Received 28 April 2025

Accepted for publication 10 September 2025

Published 19 September 2025 Volume 2025:18 Pages 13159—13172

DOI https://doi.org/10.2147/JIR.S537243

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Chaim Putterman

Qi Jiang,1,* Xin Wang,2,* Yingping Wu,3 Dawei Cui4 

1Department of Blood Transfusion, Shaoxing People’s Hospital, Shaoxing, 312000, People’s Republic of China; 2Department of Rheumatology and Immunology, Shaoxing People’s Hospital, Shaoxing, 312000, People’s Republic of China; 3Department of Laboratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, People’s Republic of China; 4Department of Blood Transfusion, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Dawei Cui, Depatmernt of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People’s Republic of China, Email daweicui@zju.edu.cn Yingping Wu, Department of Laboratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, People’s Republic of China, Email yingpingwu@zju.edu.cn

Abstract: The pathogenesis of autoimmune diseases remains unclear, which is associated with T helper (Th) cell subsets such as Th1, Th2, Treg and Tfh cells. Recent studies have indicated the involvement of N6-methyladenosine (m6A) modification in the pathogenesis of autoimmune diseases, and m6A also affects the differentiation, and function of Th cells. However, few reports focused on the relationship between m6A modification in Th cell subsets and autoimmune diseases. This review summarizes the latest research progress on m6A modification in common autoimmune diseases, specifically highlighting how various m6A-modifying enzymes influence the differentiation and function of Th cells and disease progression. Elucidating the relationship between m6A modification and Th cells in autoimmune diseases may provide a new perspective for disease prevention and targeted therapy. Finally, this review also elaborates on the impact of m6A on the clinical diagnosis and treatment of autoimmune diseases, as well as the challenges that need to be addressed.

Keywords: m6A, T helper cells, treatment, autoimmune diseases